Search - tctmd.com

Displaying 1 - 12 of 12

Sort: Relevancy | Date

News Daily News

GLP-1 Drugs in Diabetes Don’t Raise Suicidality Risk, New Data Confirm

Caitlin E. Cox

February 26, 2025

News Conference News AHA 2024

Lifestyle and Risk Factors Matter for AF Burden—Metformin May Not: TRIM-AF

Shelley Wood

November 18, 2024

News Conference News ESC 2024

Stop-or-Not: It’s OK to Tailor RAS Inhibitor Use Around Noncardiac Surgery

Todd Neale

August 30, 2024

News Conference News ACC 2024

PREVENT Supports Early PCI for Vulnerable Plaque, With Reductions in MACE

L.A. McKeown

April 08, 2024

News Daily News

Slight Risk of Interstitial Lung Disease Seen With Certain DOACs

Todd Neale

November 23, 2022

News Conference News AHA 2021

An Oral PCSK9 Inhibitor? Early Data Show Safety, Big LDL Drops

Shelley Wood

November 15, 2021

News Daily News

ACE Inhibitors/ARBs Safe, Possibly Protective in Hypertensive COVID-19 Patients

Caitlin E. Cox

April 24, 2020

News Industry News

TriNetX's Real-World Data and Analytics Platform Used to Compare Antihypertensive Treatments and Cardiovascular Events; Findings Published in the Journal of Clinical Hypertension

April 18, 2019

News Features

The Price of Knowledge: Industry-Sponsored Studies in the Era of Evidence-Based Medicine

Shelley Wood

October 22, 2018

News Daily News

Radial Access Best for PCI Following Thrombolysis in STEMI

Michael O'Riordan

November 27, 2017

News Daily News

Meta-analysis Calls Into Question Strength of Guidance for RAS Blockade in Patients With Stable CAD

Todd Neale

January 19, 2017

News Industry News

Bayer Expands Finerenone Clinical Development Program with Three Phase III Studies for Finerenone in Patients with Diabetic Kidney Disease and Patients with Chronic Heart Failure

August 31, 2015

Advertisement

GLP-1 Drugs in Diabetes Don’t Raise Suicidality Risk, New Data Confirm

Lifestyle and Risk Factors Matter for AF Burden—Metformin May Not: TRIM-AF

Stop-or-Not: It’s OK to Tailor RAS Inhibitor Use Around Noncardiac Surgery

PREVENT Supports Early PCI for Vulnerable Plaque, With Reductions in MACE

Slight Risk of Interstitial Lung Disease Seen With Certain DOACs

An Oral PCSK9 Inhibitor? Early Data Show Safety, Big LDL Drops

ACE Inhibitors/ARBs Safe, Possibly Protective in Hypertensive COVID-19 Patients

TriNetX's Real-World Data and Analytics Platform Used to Compare Antihypertensive Treatments and Cardiovascular Events; Findings Published in the Journal of Clinical Hypertension

The Price of Knowledge: Industry-Sponsored Studies in the Era of Evidence-Based Medicine

Radial Access Best for PCI Following Thrombolysis in STEMI

Meta-analysis Calls Into Question Strength of Guidance for RAS Blockade in Patients With Stable CAD

Bayer Expands Finerenone Clinical Development Program with Three Phase III Studies for Finerenone in Patients with Diabetic Kidney Disease and Patients with Chronic Heart Failure

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content